Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Diversity of human T cell receptors in tuberculosis
FY 2013-14
Summary
Mycobacterium tuberculosis (Mtb) infects one third of the global population, however only one in ten infected individuals develops active tuberculosis (TB). The reasons for progression from latent to active disease in healthy individuals have not been identified. In particular, the differences in human immune responses that determine the outcome of Mtb infection are unknown. T cells are human immune cells that recognize Mtb-infected cells through T cell receptors (TCRs). Pathogens evolve variations in proteins that are recognized by TCRs, in order to prevent immune recognition. Studies of HIV have shown that human TCRs that can recognize multiple protein variations provide a more effective immune response, and may prevent progression to AIDS. Therefore we hypothesize that individuals that contain TCRs that bind multiple protein variants are less likely to progress to active TB. To address this hypothesis, we will first characterize the TCRs that are generated in response to Mtb infection in individuals infected with Mtb in New York City. Specifically, we will determine the structure and sequences of TCRs that are restricted to one protein variant, and compare these to TCRs that are able to bind multiple protein variants. We will then use these data to characterize TCRs in people with latent TB and those that progress to active TB, through an established collaboration with colleagues in a high TB prevalence area in the Gambia. The results of our studies will offer novel insight into differential outcomes of human infection with Mtb. Furthermore we anticipate that our findings will guide vaccine development strategies by revealing differences between successful and unsuccessful human immune responses.
Department
Program
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
307702
Name
Wiens Kirsten E
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Diversity of human T cell receptors in tuberculosis
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Epitopes; Host-Pathogen Coevolution; Immune Escape; Mycobacterium Tuberculosis; T Cell Clones; T Cell Receptors
Abstract
Mycobacterium tuberculosis (Mtb) infects one third of the global population, however only one in ten infected individuals develops active tuberculosis (TB). The reasons for progression from latent to active disease in healthy individuals have not been identified. In particular, the differences in human immune responses that determine the outcome of Mtb infection are unknown. T cells are human immune cells that recognize Mtb-infected cells through T cell receptors (TCRs). Pathogens evolve variations in proteins that are recognized by TCRs, in order to prevent immune recognition. Studies of HIV have shown that human TCRs that can recognize multiple protein variations provide a more effective immune response, and may prevent progression to AIDS. Therefore we hypothesize that individuals that contain TCRs that bind multiple protein variants are less likely to progress to active TB. To address this hypothesis, we will first characterize the TCRs that are generated in response to Mtb infection in individuals infected with Mtb in New York City. Specifically, we will determine the structure and sequences of TCRs that are restricted to one protein variant, and compare these to TCRs that are able to bind multiple protein variants. We will then use these data to characterize TCRs in people with latent TB and those that progress to active TB, through an established collaboration with colleagues in a high TB prevalence area in the Gambia. The results of our studies will offer novel insight into differential outcomes of human infection with Mtb. Furthermore we anticipate that our findings will guide vaccine development strategies by revealing differences between successful and unsuccessful human immune responses.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wiens, Kirsten E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~